Banco de Chile
NYSE:BCHBanks - Regional
+$0.00 today
- Market cap
- $18.78B
- Beta
- 0.13
- P/E (TTM)
- 16.2
- EPS (TTM)
- $11.21
- Dividend yield
- 5.52%
Volume 0.27M
Average 0.41M
BCH Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Banco de ChileNYSE: BCH
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was CLP 0, compared with CLP 0 a year earlier. Trailing-twelve-month research & development was CLP 0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near CLP 0 or moves back toward the trailing-twelve-month quarterly average of CLP 0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CLP · from the income statement
- Latest · FY2025
- 0 CLP
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How BCH compares with its peers on the latest reported figures
- BCH's LTM Sep 2026 research & development of CLP 0 is the highest of the 2 companies compared; the peer median is CLP 0.
- Research & development amounts to 0.0% of revenue for BCH, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | CLP 0 | — | — | 0.0% | |
| LTM Sep 2026 | CLP 0 | — | — | 0.0% | |
| Peer median (excluding BCH) | CLP 0 | — | — | 0.0% | |
Competitors are the stored peer set for BCH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.03T | 5.31T | 5.09T | 4.65T | 3.03T |
| Cost of Revenue | 832.62B | 2.6T | 2.33T | 1.96T | 381.92B |
| Gross Profit | 2.2T | 2.71T | 2.77T | 2.69T | 2.64T |
| Gross Margin | 72.5% | 51.0% | 54.3% | 57.8% | 87.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 693.62B | 1.03T | 1.15T | 1.19T | 1.13T |
| Operating Expenses | 864.42B | 972.17B | 1.07T | 1.11T | 1.13T |
| Depreciation & Amortization | 76.8B | 84.21B | 92.31B | 94.6B | 95.11B |
| EBITDA | 1.41T | 1.82T | 1.79T | 1.68T | 1.61T |
| EBITDA Margin | 46.5% | 34.2% | 35.1% | 36.1% | 53.1% |
| Operating Income | 1.33T | 1.74T | 1.7T | 1.58T | 1.51T |
| Operating Margin | 44.0% | 32.7% | 33.3% | 34.0% | 50.0% |
| Interest Income | 2.39T | 4.47T | 4.04T | 3.77T | 2.72T |
| Interest Expense | 814.45B | 2.2T | 2.12T | 1.61T | 969.64B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 1.33T | 1.74T | 1.7T | 1.58T | 1.51T |
| Pre-Tax Margin | 44.0% | 32.7% | 33.3% | 34.0% | 50.0% |
| Income Tax Expense | 275.97B | 289.21B | 322.11B | 333.6B | 320.12B |
| Net Income | 1.06T | 1.45T | 1.37T | 1.25T | 1.19T |
| Net Margin | 34.9% | 27.2% | 27.0% | 26.9% | 39.4% |
| EPS (Basic) | 1,570.00 | 2,862.00 | 2,720.00 | 2,390.00 | 2,360.00 |
| EPS (Diluted) | 1,570.00 | 2,862.00 | 2,720.00 | 2,390.00 | 2,360.00 |
| Weighted Avg Shares | 505.09M | 505.09M | 505.09M | 505.09M | 505.2M |
| Weighted Avg Shares (Diluted) | 505.09M | 505.09M | 505.09M | 505.09M | 505.2M |
Banco de Chile
NYSE:BCH
Intrinsic Alpha fair value
Locked
Current Price
$37.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.